מדינה: ישראל
שפה: אנגלית
מקור: Ministry of Health
IVERMECTIN
BEIT-EREZ HAVAT MILATIN LTD
ORAL PASTE
IVERMECTIN 1.87 %W/W
PER OS
Required
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE SCS, FRANCE
Treatment of worm contamination in the gastro-intestinal tract in horses.
2021-09-30
Patient leaflet in accordance with the Pharmacists’ Regulations (Preparations) - 1986 VETERINARY MEDICINE PACKAGE LEAFLET This medicine is dispensed with a veterinarian’s prescription only For use in animals only 1) NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE: EQVALAN VETERINARY Oral paste. 2) ACTIVE INGREDIENT AND CONCENTRATION IN DOSE UNIT: Ivermectin 1.87% w/w For the list of the inactive ingredients and allergens in the medicine – see section 13. READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. This leaflet contains concise information about this medicine. If you have any further questions, consult the veterinarian or pharmacist. 3) WHAT IS THIS MEDICINE INTENDED FOR? The medicine is indicated for the treatment of stomach & intestine parasitic infestations in horses. At the recommended dose, the product has parasitical action against: Stomach and intestine roundworms (adults & arterial larval stages of _ Strongylus _ _vulgaris_, adults & tissue larval stages of _S. edentatus_), adults of _S._ _equinus_, adults of _Triodontophorus _ _spp._, adults and immature forms of “small” Strongyloides: _Clucodontophorus_ _spp._, _ Cycliocyclus _ _spp._ and: _Cyathostomum _ _spp._ Adults and immature forms of _Oxyuris equi_, _Habronema musca_, _Parascaris equorum_ and: _Trichostrongylus axei_. Stomach parasites: various forms of _Gastrophilus spp_. EQVALAN has parasitical action in one dose against the main internal parasites in horses. EQVALAN contains ivermectin, which has a wide range of parasitical activity, and is not a benzimidazole compound and not an organic phosphorus compound. THERAPEUTIC GROUP: This medicine belongs to the group of broad-spectrum antiparasitics for systemic (internal) use. ) CONTRAINDICATIONS: DO NOT USE THIS MEDICINE: If the animal is sensitive (allergic) to the active ingredient, the group of substances macrocyclic lactones, to which the active ingredient belongs, or to any of the other ingredients in this medicine. The active ingredient appears in sect קרא את המסמך השלם
Page 1 of 4 VETERINARY PHYSICIAN’S PRESCRIBING INFORMATION EQVALAN VETERINARY 1. NAME OF THE VETERINARY MEDICINAL PRODUCT: EQVALAN VETERINARY 2. QUALITATIVE AND QUANTITATIVE COMPOSITION: Each gram contains: Active substance: Ivermectin 18.7 mg Excipients: Titanium Dioxide (E171) 20.0 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM: Oral paste. Clean, white, homogeneous paste. 4. CLINICAL PARTICULARS: 4.1 TARGET SPECIES: Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES: The product is indicated for the treatment of stomach & intestine parasitic infestations in horses. In the recommended dose, the product has parasitical action against: Stomach & intestine roundworms (adults & arterial larval stages of _Strongylus vulgaris_, adults & tissue larval stages of _S. edentatus_), adults of _S. equinus_, adults of _Triodontophorus _ _spp_., adults & immature forms of “small” Strongyloides: _Clucodontophorus spp_., _Cycliocyclus spp_. and _Cyathostomum spp_. Adults & immature forms of _Oxyuris equi_, and adults & immature forms of _Habronema _ _musca_, _Parascaris equorum_ and _Trichostrongylus axei_. Stomach parasites: various forms of _Gastrophilus spp. _ EQVALAN has parasitical action in one dose against the main internal parasites in horses. EQVALAN contains ivermectin, which has a wide range of parasitical activity, and is not a benzimidazole compound and not an organic phosphorus compound. 4.3 CONTRA-INDICATIONS: The product has been formulated specifically for use in horses only. Dogs and cats may be adversely affected by the concentration of ivermectin in this product if they are allowed to ingest spilled paste or have access to used syringes. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES: Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing, קרא את המסמך השלם